?

Proehl Gerald T

Director
Tenax Therapeutics, Inc.
US, Morrisville [HQ]
CIK 1279191

Data Source

We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.

Latest Information

Shares :
1,667
Price per Share :
$6.48
Equivalence :
$10,802.16

Transaction History

  • 1,667 Shares After Transaction
    Value : $n/a
    $0.0
    08/08/24
  • Footnotes:
    #1 On August 8, 2024, as part of a private placement of the Issuer's securities, the Reporting Person purchased shares of the Issuer's common stock ("Shares") and a pre-funded warrant to purchase Shares, along with a warrant to purchase Shares, pursuant to the terms of a Securities Purchase Agreement, dated August 6, 2024, by and among the Issuer, Reporting Person and certain other accredited investors. The purchase price for each Share and accompanying warrant (reported in Table II) is $3.00. The purchase price for each pre-funded warrant and accompanying warrant (reported in Table II) is $2.99.
    #2 The aggregate number of shares of common stock previously reported as 1,495, but were adjusted to reflect the stock splits that occurred on January 4, 2023 and January 2, 2024.